Prenosis Inc.

Prenosis Inc. is an artificial intelligence company pioneering precision medicine in acute care. Our Immunix™ precision medicine platform drives the development of precision products and enables real-time delivery of optimal therapy. We've created and validated the first FDA-authorized AI biomarker for sepsis, the Sepsis ImmunoScore™. The Sepsis ImmunoScore™ is the first FDA-authorized AI diagnostic for sepsis, providing real-time critical information and predictions for patients. Our platform integrates biomarkers and clinical data to expedite the delivery of optimal therapy. Prenosis is building the world's largest biobank linked to clinical data for infection in acute care, enabling the development and validation of new precision medicine tools. We have partnerships with major healthcare providers and have been featured in top medical journals and news outlets. Our team is dedicated to advancing precision medicine and improving patient outcomes through innovative AI solutions. We are a growth-stage company with significant opportunities for career development and impact. Prenosis is an Equal Opportunity Employer.